Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
LENALIDOMIDE
EZB-MYC+ Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P1/2
CCC
(48)
Lentivirus Vector CCR5 shRNA
Hodgkins Lymphoma
AIDS Malignancy Consortium
P1/2
CCC
(48)
Lentivirus Vector CCR5 shRNA
Non-Hodgkin Lymphoma
AIDS Malignancy Consortium
P1/2
CCC
(48)
Lentivirus Vector CCR5 shRNA
Burkitt Lymphoma
AIDS Malignancy Consortium
P1/2
CCC
(48)
Lentivirus Vector CCR5 shRNA
Follicular Lymphoma
AIDS Malignancy Consortium
P1/2
CCC
(48)
Lentivirus Vector CCR5 shRNA
Mantle Cell Lymphoma
AIDS Malignancy Consortium
P1/2
CCC
(48)
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells
Hodgkins Lymphoma
AIDS Malignancy Consortium
P1/2
CCC
(48)
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells
Follicular Lymphoma
AIDS Malignancy Consortium
P1/2
CCC
(48)
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells
Mantle Cell Lymphoma
AIDS Malignancy Consortium
P1/2
CCC
(48)
Lenvatinib
Breast Tumor Luminal A Or B
Salubris Biotherapeutics Inc
P1/2
CCC
(48)
Levodopa
Multiple System Atrophy, Parkinsonian Type
Julien Bally
P1/2
CCC
(48)
Levodopa
Orthostatic Hypotension
Julien Bally
P1/2
CCC
(48)
Ligufalimab
Acute Myeloid Leukemia
Akeso
P1/2
CCC
(48)
Linperlisib
Lymphoma
The First Hospital of Jilin University
P1/2
CCC
(48)
Linperlisib
Extranodal Nasal NK/T Cell Lymphoma
Beijing Tongren Hospital
P1/2
CCC
(48)
Linperlisib
Plasma Cell Myeloma
Fuling Zhou
P1/2
CCC
(48)
lis1
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Xenothera SAS
P1/2
CCC
(48)
Lisaftoclax
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sun Yat-sen University
P1/2
CCC
(48)
lm-299
Cancer
LaNova Medicines Limited
P1/2
CCC
(48)
lm-350 for
Cancer
LaNova Medicines Limited
P1/2
CCC
(48)
LMP744
Central Nervous System Neoplasm
National Institute of Neurological Disorders and Stroke (NINDS)
P1/2
CCC
(48)
Lmv-12
RET Fusion Positive Cancer
Hunan Province Tumor Hospital
P1/2
CCC
(48)
Locnartecan
Ewing Sarcoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Loperamide
Ovarian Cancer
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Low-Dose Can103
Gaucher Disease Type III
CANbridge (Suzhou) Bio-pharma Co., Ltd.
P1/2
CCC
(48)
Showing 1426 to 1450 of 6,308 assets
Previous
Page 58 of 253
Next